PRODUCTS
LiverMultiScan
LiverMultiScan is a noninvasive MRI scan that accurately assesses signs of liver disease, offering a complete picture of liver health.
A new way to see liver health
LiverMultiScan is best in class. It is a viable alternative to liver biopsy and outperforms other non-invasive tests in the detection and stratification of MASH
Avoids biopsy risk of complications
Detects change more reliably than competitors
Outperforms other tests in the detection and stratification of MASH
Correlates with biopsy features (NAS and fibrosis)
Lower failure rates compared to elastography, even in high BMI
More robust compared to other tests in MASLD, MASH, and CLD patients
No need for contrast agent, needles, or exposure to radiation
LiverMultiScan predicts cardiovascular and liver related outcomes in patients with chronic liver disease
Prognostic value of both major liver and cardiovascular outcomes
High cT1 linked to CVD events and mortality
Predicts CVD hospitalisation in a population cohort where PDFF and FIB-4 do not
Supports broader risk stratification
LiverMultiScan is cost-effective for diagnosis and monitoring of metabolic liver disease compared to alternative methods, reducing unnecessary procedures and healthcare resources
cT1-based care pathways deliver the lowest per-patient cost compared to biopsy or FibroScan (VCTE)
Reduces need for specialist visits, biopsies, and imaging procedures, streamlining the patient pathway
Demonstrated favorable cost-effectiveness (ICER ~€4,900 per QALY) across multiple healthcare systems
Minimizes complication costs and improves safety versus invasive liver biopsy
Supports scalable adoption of noninvasive liver assessment within constrained healthcare budgets
LiverMultiScan provides accurate, quantitative measures to support early detection of liver changes and monitoring of treatment response
Single scan provides a comprehensive liver assessment
Accurate, repeatable data for confident diagnosis
Enables timely intervention
Enables personalised and preventative treatment
Identifies MASH patients eligible for treatment
Standardized, reproducible & repeatable metrics ensuring consistent results
Unique clinical insights
cT1 is a clinically meaningful metric that enables diagnosis and effective monitoring of treatment response.
Nationwide payor coverage
LiverMultiScan has widespread insurance coverage.
Non-invasive procedure
Delivered through MRI, LiverMultiScan is a safe and painless procedure that does not require specialist equipment or contrast agents.
Patient centric reports
Results are presented in an intuitive and easy to understand report.
Explore
Clear, repeatable, and standardized metrics delivered through a secure and compliant platform, seamlessly integrating with your reporting software and timelines.
Product overview
An introduction for healthcare professionals wanting to know more about the clinical utility of LiverMultiScan.
Research publications
A curated document list highlighting the utility and performance of LiverMultiScan.
How it works
A technical overview of how results are generated and returned to your healthcare provider.
Introducing body composition analysis
Complete the picture
Quick, safe and pain free assessment of an individual's metabolic health
Fat and muscle quantification
Precise quantification of visceral, subcutaneous adipose tissue and skeletal muscle.
Comprehensive liver assessment
Standardised and validated metrics providing a comprehensive liver health assessment.
A true window into metabolic health
Measure what matters. Combining Perspectum's LiverMultiScan and VitruvianScan provides insights enabling personalised and patient-centric care.